Log in to save to my catalogue

Bivalent promoter hypermethylation in cancer is linked to the H327me3/H3K4me3 ratio in embryonic ste...

Bivalent promoter hypermethylation in cancer is linked to the H327me3/H3K4me3 ratio in embryonic ste...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cc3fa85d4d5d449588d39054315791cf

Bivalent promoter hypermethylation in cancer is linked to the H327me3/H3K4me3 ratio in embryonic stem cells

About this item

Full title

Bivalent promoter hypermethylation in cancer is linked to the H327me3/H3K4me3 ratio in embryonic stem cells

Publisher

England: BioMed Central Ltd

Journal title

BMC biology, 2020-03, Vol.18 (1), p.25-25, Article 25

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Thousands of mammalian promoters are defined by co-enrichment of the histone tail modifications H3K27me3 (repressive) and H3K4me3 (activating) and are thus termed bivalent. It was previously observed that bivalent genes in human ES cells (hESC) are frequent targets for hypermethylation in human cancers, and depletion of DNA methylation in mouse emb...

Alternative Titles

Full title

Bivalent promoter hypermethylation in cancer is linked to the H327me3/H3K4me3 ratio in embryonic stem cells

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_cc3fa85d4d5d449588d39054315791cf

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cc3fa85d4d5d449588d39054315791cf

Other Identifiers

ISSN

1741-7007

E-ISSN

1741-7007

DOI

10.1186/s12915-020-0752-3

How to access this item